Since March 2020, global supply chains have been significantly disrupted in almost every industry. Surveys conducted in March by the Institute of Supply Chain Management revealed that a staggering 75 percent of companies report supply chain disruptions.1 The US healthcare industry, representing 17.7 percent of GDP,2 has been broadly impacted. In addition to the well-publicized concerns about shortages of ventilators and PPE, in the first two months since the pandemic began, 15 new drugs were added to the FDA drug shortage list.3 Most of us saw ourselves impacted as customers of the consumer pa…
Read the full article at texasceomagazine.com…
Filled under News
Curated by Chief Operating Officer Blog
